Quantinno Capital Management LP Raises Stock Holdings in Cencora, Inc. $COR

Quantinno Capital Management LP increased its stake in Cencora, Inc. (NYSE:COR) by 4.5% during the 1st quarter, Holdings Channel reports. The firm owned 102,827 shares of the company’s stock after purchasing an additional 4,423 shares during the quarter. Quantinno Capital Management LP’s holdings in Cencora were worth $32,302,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Kemnay Advisory Services Inc. bought a new position in shares of Cencora in the 4th quarter worth $25,000. Oakworth Capital Inc. purchased a new stake in shares of Cencora during the 4th quarter valued at $26,000. Elyxium Wealth LLC bought a new stake in shares of Cencora during the 4th quarter worth $27,000. Archer Investment Corp grew its position in Cencora by 134.3% in the fourth quarter. Archer Investment Corp now owns 82 shares of the company’s stock worth $28,000 after acquiring an additional 47 shares in the last quarter. Finally, Motiv8 Investments LLC bought a new position in Cencora in the fourth quarter valued at $29,000. 97.52% of the stock is owned by hedge funds and other institutional investors.

Cencora Price Performance

COR opened at $312.40 on Friday. The company has a debt-to-equity ratio of 3.40, a current ratio of 0.95 and a quick ratio of 0.59. The stock’s 50 day simple moving average is $289.36 and its 200 day simple moving average is $315.60. The firm has a market cap of $60.78 billion, a price-to-earnings ratio of 23.96, a PEG ratio of 1.73 and a beta of 0.58. Cencora, Inc. has a 1 year low of $244.82 and a 1 year high of $377.54.

Cencora (NYSE:COR) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $4.75 earnings per share for the quarter, missing the consensus estimate of $4.82 by ($0.07). The company had revenue of $78.36 billion during the quarter, compared to the consensus estimate of $81.09 billion. Cencora had a net margin of 0.78% and a return on equity of 135.20%. The business’s revenue for the quarter was up 3.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $4.42 EPS. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. As a group, analysts predict that Cencora, Inc. will post 17.79 earnings per share for the current year.

Cencora Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Friday, May 15th were issued a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date was Friday, May 15th. Cencora’s dividend payout ratio is currently 18.40%.

Cencora announced that its board has authorized a share buyback program on Thursday, May 21st that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the company to purchase up to 3.9% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s management believes its stock is undervalued.

Analyst Ratings Changes

COR has been the topic of a number of research reports. Morgan Stanley set a $342.00 price target on Cencora in a research report on Friday, May 8th. UBS Group increased their price objective on Cencora from $410.00 to $412.00 and gave the company a “buy” rating in a research report on Thursday, May 7th. William Blair started coverage on Cencora in a research report on Tuesday, April 28th. They set a “market perform” rating on the stock. Wells Fargo & Company dropped their target price on Cencora from $429.00 to $331.00 and set an “overweight” rating for the company in a research report on Monday, May 11th. Finally, Barclays cut their target price on Cencora from $425.00 to $350.00 and set an “overweight” rating for the company in a research note on Wednesday, June 10th. Eleven research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $367.75.

Insiders Place Their Bets

In other news, Director Lauren M. Tyler purchased 550 shares of the company’s stock in a transaction on Monday, June 22nd. The stock was acquired at an average price of $270.23 per share, with a total value of $148,626.50. Following the transaction, the director directly owned 4,359 shares of the company’s stock, valued at approximately $1,177,932.57. This represents a 14.44% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.38% of the stock is owned by insiders.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.